ATRA

Atara Biotherapeutics, Inc

Price

$9.07

return (12m)

-26.62%

p/e

-8.51

p/bv

-3.84

DIVIDEND YIELD

0.00%

ATRA price

Atara Biotherapeutics, Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ATRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

12.74%

3 months

-13.04%

1 year

-26.62%

2 years

31.45%

5 years

-97.53%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ATRA

Valuation

P/E

-8.51

Sector 7.65

Industry 7.65

P/BV

-3.84

Sector 1.91

Industry 1.91

P/Revenue (PSR)

22.89

Sector 1.92

Industry 1.92

EV/EBITDA

Sector -630.62

Industry -630.62

EV/EBIT

Sector -7,206,132,315.43

Industry -7,206,132,315.43

P/EBITDA

Sector -92.86

Industry -92.86

P/EBIT

Sector -91.56

Industry -91.56

P/Total Assets

6.75

Sector 0.90

Industry 0.90

P/Net Current Assets

-3.19

Sector -2.52

Industry -2.52

P/Working Capital

21.24

Sector -4,940.99

Industry -4,940.99

EPS

-1.11

Sector 0.72

Industry 0.72

BVPS

-2.47

Sector 9.67

Industry 9.67

Efficiency

Gross Margin

100.00%

Sector 34.42%

Industry 34.42%

EBITDA Margin

0.00%

Sector 2.06%

Industry 2.06%

EBIT Margin

0.00%

Sector 0.23%

Industry 0.23%

Operating Margin

-100.00%

Sector 4.20%

Industry 4.20%

Net Profit Margins

-100.00%

Sector 2.40%

Industry 2.40%

Asset Turnover

0.03

Sector 0.11

Industry 0.11

Profitability

ROE

45.08%

Sector 1.42%

Industry 1.42%

ROA

-79.35%

Sector -0.76%

Industry -0.76%

ROIC

0.00%

Sector -65.52%

Industry -65.52%

Dividends

Dividend yield

0.00%

Sector 0.49%

Industry 0.49%

Payout

Sector 10.08%

Industry 10.08%

Debt

Current Ratio

1.98

Sector 1.44

Industry 1.44

Net Debt / EBITDA

Sector -109,118,343.39

Industry -109,118,343.39

Net Debt / EBIT

Sector -82.02

Industry -82.02

Net Debt / Equity

0.00

Sector -0.79

Industry -0.79

Gross Debt / Equity

0.00

Sector -0.39

Industry -0.39

Equity/Assets

-1.76

Sector 0.42

Industry 0.42

Liabilities/Assets

2.76

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

-21.15%

Sector -

Industry -

5Y Earnings CAGR

-45.28%

Sector -

Industry -

Fundamentals ATRA

DRAG THE FRAME TO SEE MORE DATA

ATRA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Atara Biotherapeutics, Inc

Atara Biotherapeutics, Inc

Average Investor10 user rating

4.0 (2 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Atara Biotherapeutics, Inc (United States) is listed on the Nasdaq and has a market capitalization of $141.90 million, with shareholders equity totaling $-37.00 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Atara Biotherapeutics, Inc reported $6.20 million in revenue, generating net income of $-16.68 million.

Key financial metrics include a P/E ratio of -8.51, a price-to-book (P/B) ratio of -3.84, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ATRA.

Market cap

$141.90 million

Net worth

$-37.00 million

$-37,000,000.00

Assets

$21.02 million

$21,020,000.00

Total Shares Outstanding

15.00 million

15,000,000

Average Daily Trading Volume

$69.35 Thousand

$69,345.82

Sector

Others

Industry

Others

ATRA

ATRA revenue and profits

Financial Results ATRA

DRAG THE FRAME TO SEE MORE DATA

ATRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$394.67 31,55% (12M)

P/E

23.98

2.26%

ROE

14.27%

P/BV

3.42

SHEL - Shell PLC ADR

$90.87 28,85% (12M)

P/E

9.92

3.21%

ROE

14.29%

P/BV

1.42

STLA - Stellantis NV

$5.40 --43,93% (12M)

P/E

-0.59

0.00%

ROE

-35.93%

P/BV

0.21

COR - Cencora Inc.

$322.26 11,56% (12M)

P/E

23.63

0.73%

ROE

81.48%

P/BV

19.25

SSNLF - Samsung Electronics Co Ltd

$65.21 62,28% (12M)

P/E

0.00

0.00%

ROE

7,749.65%

P/BV

0.00

ALIZY - Allianz SE ADR

$51.73 --7,97% (12M)

P/E

14.28

2.63%

ROE

17.89%

P/BV

2.55

TTE - TotalEnergies SE ADR

$86.62 49,34% (12M)

P/E

7.18

4.53%

ROE

21.42%

P/BV

1.54

NSRGY - Nestle SA ADR

$97.10 7,42% (12M)

P/E

12.00

4.01%

ROE

58.05%

P/BV

6.97